176 related articles for article (PubMed ID: 37115543)
1. Practice-Level Variation in Molecular Testing and Use of Targeted Therapy for Patients With Non-Small Cell Lung Cancer and Colorectal Cancer.
Roberts TJ; Kehl KL; Brooks GA; Sholl L; Wright AA; Landrum MB; Keating NL
JAMA Netw Open; 2023 Apr; 6(4):e2310809. PubMed ID: 37115543
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of Reliability and Correlations of Quality Measures in Cancer Care.
Keating NL; Cleveland JLF; Wright AA; Brooks GA; Meneades L; Riedel L; Zubizarreta JR; Landrum MB
JAMA Netw Open; 2021 Mar; 4(3):e212474. PubMed ID: 33749769
[TBL] [Abstract][Full Text] [Related]
3. Association of Broad-Based Genomic Sequencing With Survival Among Patients With Advanced Non-Small Cell Lung Cancer in the Community Oncology Setting.
Presley CJ; Tang D; Soulos PR; Chiang AC; Longtine JA; Adelson KB; Herbst RS; Zhu W; Nussbaum NC; Sorg RA; Agarwala V; Abernethy AP; Gross CP
JAMA; 2018 Aug; 320(5):469-477. PubMed ID: 30088010
[TBL] [Abstract][Full Text] [Related]
4. Adoption of Innovative Therapies Across Oncology Practices-Evidence From Immunotherapy.
Carroll CE; Landrum MB; Wright AA; Keating NL
JAMA Oncol; 2023 Mar; 9(3):324-333. PubMed ID: 36602811
[TBL] [Abstract][Full Text] [Related]
5. Use of a Novel Network-Based Linchpin Score to Characterize Accessibility to the Oncology Physician Workforce in the United States.
Moen EL; Brooks GA; O'Malley AJ; Schaefer A; Carlos HA; Onega T
JAMA Netw Open; 2022 Dec; 5(12):e2245995. PubMed ID: 36525275
[TBL] [Abstract][Full Text] [Related]
6. Improving biomarker testing in advanced non-small-cell lung cancer and metastatic colorectal cancer: experience from a large community oncology network in the USA.
Schwartzberg L; Daniel D; Vaena D; Slater D; Staszewski H; Fang B; Seneviratne L; Yu E; Price R; Szado T; Meyer CS; Shah A; Ma E
Future Oncol; 2023 Jun; 19(20):1397-1414. PubMed ID: 37318757
[TBL] [Abstract][Full Text] [Related]
7. Variation in Use of Lung Cancer Targeted Therapies Across State Medicaid Programs, 2020-2021.
Roberts TJ; Kesselheim AS; Avorn J
JAMA Netw Open; 2023 Jan; 6(1):e2252562. PubMed ID: 36696113
[TBL] [Abstract][Full Text] [Related]
8. Incident colorectal cancer screening and associated healthcare resource utilization and Medicare cost among Medicare beneficiaries aged 66-75 years in 2016-2018.
Li S; Miller-Wilson LA; Guo H; Hoover M; Fisher DA
BMC Health Serv Res; 2022 Oct; 22(1):1228. PubMed ID: 36192728
[TBL] [Abstract][Full Text] [Related]
9. Disparities and Trends in Genetic Testing and Erlotinib Treatment among Metastatic Non-Small Cell Lung Cancer Patients.
Palazzo LL; Sheehan DF; Tramontano AC; Kong CY
Cancer Epidemiol Biomarkers Prev; 2019 May; 28(5):926-934. PubMed ID: 30787053
[TBL] [Abstract][Full Text] [Related]
10. KRAS mutations in non-small-cell lung cancer and colorectal cancer: implications for EGFR-targeted therapies.
Maus MK; Grimminger PP; Mack PC; Astrow SH; Stephens C; Zeger G; Hsiang J; Brabender J; Friedrich M; Alakus H; Hölscher AH; Lara P; Danenberg KD; Lenz HJ; Gandara DR
Lung Cancer; 2014 Feb; 83(2):163-7. PubMed ID: 24331409
[TBL] [Abstract][Full Text] [Related]
11. Molecular profile of KRAS G12C-mutant colorectal and non-small-cell lung cancer.
Araujo LH; Souza BM; Leite LR; Parma SAF; Lopes NP; Malta FSV; Freire MCM
BMC Cancer; 2021 Feb; 21(1):193. PubMed ID: 33632153
[TBL] [Abstract][Full Text] [Related]
12. Real-World Costs of Adverse Events in First-Line Treatment of Metastatic Non-Small Cell Lung Cancer.
Engel-Nitz NM; Johnson MP; Bunner SH; Ryan KJ
J Manag Care Spec Pharm; 2020 Jun; 26(6):729-740. PubMed ID: 32463768
[TBL] [Abstract][Full Text] [Related]
13. Correlation Between Surrogate End Points and Overall Survival in a Multi-institutional Clinicogenomic Cohort of Patients With Non-Small Cell Lung or Colorectal Cancer.
Kehl KL; Riely GJ; Lepisto EM; Lavery JA; Warner JL; LeNoue-Newton ML; Sweeney SM; Rudolph JE; Brown S; Yu C; Bedard PL; Schrag D; Panageas KS;
JAMA Netw Open; 2021 Jul; 4(7):e2117547. PubMed ID: 34309669
[TBL] [Abstract][Full Text] [Related]
14. EGFR mutation testing and TKI treatment patterns among veterans with stage III and IV non-small cell lung cancer.
Hung A; Lee KM; Alba PR; Li Y; Gao AZ; Hintze BJ; Efimova OV; Shenolikar R; Pavilack M; Simmons D; Kelley MJ; Lynch JA; Reed SD
Cancer Treat Res Commun; 2021; 27():100327. PubMed ID: 33549984
[TBL] [Abstract][Full Text] [Related]
15. Association Between First-Line Immune Checkpoint Inhibition and Survival for Medicare-Insured Patients With Advanced Non-Small Cell Lung Cancer.
Kehl KL; Greenwald S; Chamoun NG; Manberg PJ; Schrag D
JAMA Netw Open; 2021 May; 4(5):e2111113. PubMed ID: 34019086
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of biweekly i.v. administrations of the Aurora kinase inhibitor danusertib hydrochloride in independent cohorts of patients with advanced or metastatic breast, ovarian, colorectal, pancreatic, small-cell and non-small-cell lung cancer: a multi-tumour, multi-institutional phase II study.
Schöffski P; Besse B; Gauler T; de Jonge MJ; Scambia G; Santoro A; Davite C; Jannuzzo MG; Petroccione A; Delord JP
Ann Oncol; 2015 Mar; 26(3):598-607. PubMed ID: 25488684
[TBL] [Abstract][Full Text] [Related]
17. Assessing Colorectal Cancer Screening Adherence of Medicare Fee-for-Service Beneficiaries Age 76 to 95 Years.
Bian J; Bennett C; Cooper G; D'Alfonso A; Fisher D; Lipscomb J; Qian CN
J Oncol Pract; 2016 Jun; 12(6):e670-80. PubMed ID: 27189357
[TBL] [Abstract][Full Text] [Related]
18. First-line treatment of advanced epidermal growth factor receptor (EGFR) mutation positive non-squamous non-small cell lung cancer.
Greenhalgh J; Boland A; Bates V; Vecchio F; Dundar Y; Chaplin M; Green JA
Cochrane Database Syst Rev; 2021 Mar; 3(3):CD010383. PubMed ID: 33734432
[TBL] [Abstract][Full Text] [Related]
19. Disparities in Biomarker Testing and Clinical Trial Enrollment Among Patients With Lung, Breast, or Colorectal Cancers in the United States.
Bruno DS; Hess LM; Li X; Su EW; Patel M
JCO Precis Oncol; 2022 Jun; 6():e2100427. PubMed ID: 35737912
[TBL] [Abstract][Full Text] [Related]
20. Treatment and Survival of Medicare Beneficiaries with Colorectal Cancer: A Comparative Analysis Between a Rural State Cancer Registry and National Data.
Rane PB; Madhavan SS; Sambamoorthi U; Sita K; Kurian S; Pan X
Popul Health Manag; 2017 Feb; 20(1):55-65. PubMed ID: 27419662
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
